Comments
Loading...

Mira Pharmaceuticals

MIRANASDAQ
Logo brought to you by Benzinga Data
$1.06
0.066.00%
At close: -
$1.09
0.032.83%
After Hours: Dec 20, 7:45 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$17.00
Lowest Price Target1
$11.00
Consensus Price Target1
$14.00

Mira Pharmaceuticals (NASDAQ:MIRA) Stock, Analyst Ratings, Price Targets, Forecasts

Mira Pharmaceuticals Inc has a consensus price target of $14 based on the ratings of 2 analysts. The high is $17 issued by Rodman & Renshaw on September 30, 2024. The low is $11 issued by Ascendiant Capital on August 5, 2024. The 2 most-recent analyst ratings were released by Rodman & Renshaw and Ascendiant Capital on September 30, 2024 and August 5, 2024, respectively. With an average price target of $14 between Rodman & Renshaw and Ascendiant Capital, there's an implied 1184.40% upside for Mira Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Rodman & Renshaw
Ascendiant Capital

1calculated from analyst ratings

Analyst Ratings for Mira Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Mira Pharmaceuticals (MIRA) stock?

A

The latest price target for Mira Pharmaceuticals (NASDAQ:MIRA) was reported by Rodman & Renshaw on September 30, 2024. The analyst firm set a price target for $17.00 expecting MIRA to rise to within 12 months (a possible 1459.63% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Mira Pharmaceuticals (MIRA)?

A

The latest analyst rating for Mira Pharmaceuticals (NASDAQ:MIRA) was provided by Rodman & Renshaw, and Mira Pharmaceuticals initiated their buy rating.

Q

When was the last upgrade for Mira Pharmaceuticals (MIRA)?

A

There is no last upgrade for Mira Pharmaceuticals

Q

When was the last downgrade for Mira Pharmaceuticals (MIRA)?

A

There is no last downgrade for Mira Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Mira Pharmaceuticals (MIRA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mira Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mira Pharmaceuticals was filed on September 30, 2024 so you should expect the next rating to be made available sometime around September 30, 2025.

Q

Is the Analyst Rating Mira Pharmaceuticals (MIRA) correct?

A

While ratings are subjective and will change, the latest Mira Pharmaceuticals (MIRA) rating was a initiated with a price target of $0.00 to $17.00. The current price Mira Pharmaceuticals (MIRA) is trading at is $1.09, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch